Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03039257 · ClinicalTrials.gov registry record · NA
Vitamin A Replacement in Patients Undergoing HSCT and Its Role on MBI-LCBI Rates
A NA study of Hematopoietic Stem Cell Transplant, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT03039257 is a NA study of Hematopoietic Stem Cell Transplant that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 12 participants, below the 103-participant average among 8 other Hematopoietic Stem Cell Transplant trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03039257, a NA study of Hematopoietic Stem Cell Transplant, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to establish that single dose vitamin A supplementation is feasible and safe in pediatric and young adult bone marrow transplant recipients until day +30 (± 7 days) after hematopoietic stem cell transplantation.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Vitamin A
Study Locations (1)
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2017-02-02 |
| Est. Completion | 2018-03-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03039257
The ClinicalTrials.gov registry entry for NCT03039257 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 103-participant average among 8 other Hematopoietic Stem Cell Transplant trials with a reported enrollment target (88% lower). The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hematopoietic Stem Cell Transplant appearing as the primary indexed condition, and to 1 intervention - of which Vitamin A is the first listed.
NCT03039257 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT03039257 about?
NCT03039257 is a clinical study titled "Vitamin A Replacement in Patients Undergoing HSCT and Its Role on MBI-LCBI Rates". The primary objective of this study is to establish that single dose vitamin A supplementation is feasible and safe in pediatric and young adult bone marrow transplant recipients until day +30 (± 7 days) after hematopoietic stem cell transplantation.
What is the current status of trial NCT03039257?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2017-02-02. Estimated completion is 2018-03-28.
What conditions does trial NCT03039257 study?
This clinical trial studies the following conditions: Hematopoietic Stem Cell Transplant.
What interventions are being tested in trial NCT03039257?
The interventions under investigation include: Vitamin A (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03039257?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03039257 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hematopoietic Stem Cell Transplant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors
RECRUITING · NA
-
Prehabilitation Program to Improve Cardiac Reserve in High-Risk Patients Undergoing Hematopoietic Stem Cell Transplantation
RECRUITING · NA
-
Coping Skills Training for Symptom Management and Daily Steps (Step Up)
RECRUITING · NA
-
Music Therapy and Hematopoietic Stem Cell Transplant
COMPLETED · NA
-
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
RECRUITING · Phase 1
-
T Cell Therapy of Opportunistic Cytomegalovirus Infection
RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.